Champions Oncology (NASDAQ:CSBR) Bolsa, Quote.MetaTitle.unusual-options

Champions Oncology

Champions Oncology Inc

Atlantic International Corp. - Common Stock

Atlantic International

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

CDT Equity

Codexis

Harvard Bioscience

MindWalk Holdings

Lifecore Biomedical

Mesa Laboratories

MaxCyte

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Champions Oncology (CSBR) Previsión

Noticias

Beneficios

Opciones

Pronóstico

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Comments

Champions Oncology Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL